Quince Therapeutics Inc (QNCX)

NASDAQ
1.33
-0.07(-5.00%)
After Hours
1.34
+0.01(+0.75%)
- Real-time Data
  • Volume:
    131,978
  • Day's Range:
    1.29 - 1.46
  • 52 wk Range:
    1.20 - 98.50

QNCX Overview

Prev. Close
1.4
Day's Range
1.29-1.46
Revenue
-
Open
1.29
52 wk Range
1.2-98.5
EPS
-2.72
Volume
131,978
Market Cap
48.02M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
256,607
P/E Ratio
-0.679
Beta
1.22
1-Year Change
-98.55%
Shares Outstanding
36,104,130
Next Earnings Date
Nov 16, 2022
What is your sentiment on Quince Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Quince Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Quince Therapeutics Inc Analysis

Quince Therapeutics Inc Company Profile

Quince Therapeutics Inc Company Profile

Employees
55

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralStrong SellSellStrong Sell
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Sell
SummaryNeutralSellStrong SellStrong SellStrong Sell
  • Well, we'll have to buy this failure for $5.9 soon we'll see fireworks here and witness how she will go crazy. I expect double digits.
    0
    • You can buy it now under 3
      0
    • under 2?
      0
    • 1 maybe?
      0
  • Going to zero
    0
    • 15% intraday price action. Shorters are in charge because of T/L selling EOY. They must cover.
      0
      • I love a good potential Squeeze setup especially when its "Numero uno," on the largest Shorts Vs the Float list.
        0
        • something is going on. it will go up to 30 soon
          1
          • This is the price target from HC Hainwright (they corrected it from 200, LOL).
            0
        • We may get Alzheimer earlier than break-even.
          0
          • This algo trading confuses all technical analysis.
            0
            • time travel is possible, here you can see 2019 ipo prices.
              0
              • It will back to 30 in 15 days.
                0
                • 15 days pases and fell another 35%
                  0
              • Doesnt go from 115 to 15 for nothing. This company is done
                2